The CAVATAK brand, founded in 2005 (Australia), from 402 sister brands and 17477 competing brands. CAVATAK is owned by Merck & Co, listed on the stock exchange of New York The sector of CAVATAK is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Merck & Co
(CAVATAK)
over 5 years*
USD 219.35